01—Abstract
Summary
Summary of the 8-K filed April 11, 2022. Cited figures are marked; the original filing is the authoritative source.
Moderna, Inc. (MRNA) announced a significant change in its executive leadership with the appointment of Jorge M.
Gomez as its new Chief Financial Officer (CFO), effective May 9, 2022. Mr. Gomez brings extensive financial experience, having most recently served as CFO of Dentsply Sirona and previously holding senior finance roles at Cardinal Health. This transition comes as the current CFO, David Meline, retires from his role on the same date but will remain with the company as a consultant until July 8, 2024, to ensure a smooth handover.
The filing details Mr. Gomez's compensation package, including a base salary, bonus potential, a signing bonus, and a substantial new hire equity award with a four-year vesting period. The company is also disclosing the terms of Mr. Meline's retirement and consulting agreement, which includes continued vesting of certain equity awards.
02—Key points
Key Highlights
- Appointment of Jorge M. Gomez as new Chief Financial Officer (CFO) effective May 9, 2022.
- Retirement of current CFO David Meline effective May 9, 2022, with transition to a consulting role until July 8, 2024.
- Mr. Gomez's compensation includes an annual base salary of $700,000, annual bonus potential targeting 90% of base salary, a $500,000 signing bonus, and a $4,000,000 new hire equity award (4-year vesting).
- The new hire equity award for Mr. Gomez offers flexibility in its form (stock options, RSUs, or a combination).
- Mr. Meline will continue to receive his current salary and benefits until retirement and will vest in outstanding equity awards through July 6, 2024, as part of his consulting agreement.
- The company issued a press release on April 11, 2022, announcing these executive changes.
03—Questions
Frequently Asked Questions
Who is replacing David Meline as CFO?
Jorge M. Gomez has been appointed as the new Chief Financial Officer (CFO) of Moderna, Inc., effective May 9, 2022.
What is David Meline's role after retiring as CFO?
David Meline will retire as CFO on May 9, 2022, but will remain with Moderna as a consultant to assist with the transition until July 8, 2024. He will continue to receive his current salary and benefits during the transition period and will vest in certain outstanding equity awards through July 6, 2024.
What is Jorge M. Gomez's compensation package?
Mr. Gomez will receive an annual base salary of $700,000, be eligible for an annual cash bonus with a target of 90% of his base salary, a $500,000 signing bonus, and a new hire equity award valued at $4,000,000, which vests over four years. He will also be eligible for future annual equity awards and other standard executive benefits.
Where did the new CFO, Jorge M. Gomez, work previously?
Before joining Moderna, Mr. Gomez served as Executive Vice President and CFO of Dentsply Sirona from August 2019. Prior to that, he held various roles of increasing responsibility at Cardinal Health since 2006, most recently as CFO.
04—Continue